Drug-Resistant Epilepsy: Is It Really Sometimes RRMS (Relapsing-Remitting Multiple Seizures)?

Epilepsy Currents - United States
doi 10.5698/1535-7511-17.1.32
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

SAGE Publications

Related search

Real-Life Effectiveness of Natalizumab in Relapsing-Remitting Multiple Sclerosis (Rrms): A Registry Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Immune Thrombocytopenia (ITP) in a Patient With Relapsing-Remitting Multiple Sclerosis (RRMS) Associated With B-Interferon-1α Treatment

Indian Journal of Pharmaceutical Education and Research
ToxicologyPharmaceuticsPharmacology
2018English

Intestinal Permeability in Relapsing-Remitting Multiple Sclerosis

Neurotherapeutics
NeurologyPharmacology
2017English

Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis

Archives of Neurology
2009English

Pnd155 - Reduced Relapse Rates and Improved Quality of Life for Relapsing-Remitting Multiple Sclerosis (Rrms) Patients Treated With Natalizumab vs Injectable Therapies

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Disease-Modifying Therapies in Relapsing–remitting Multiple Sclerosis

Neuropsychiatric Disease and Treatment
PsychiatryMental HealthBiological Psychiatry
2010English

Natalizumab: A New Treatment for Relapsing Remitting Multiple Sclerosis

Therapeutics and Clinical Risk Management
Chemical HealthPharmacologySafetyMedicineToxicologySafety ResearchPharmaceutics
2007English

Stressful Events Increase Exacerbations in Relapsing-Remitting Multiple Sclerosis

BMJ
2003English

Efficacy of Vagal Nerve Stimulation for Drug-Resistant Epilepsy: Is It the Stimulation or Medication?

Canadian Journal of Neurological Sciences
MedicineNeurology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy